Stanley Szefler
University of Colorado Denver
H-index: 120
North America-United States
Top articles of Stanley Szefler
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
How Should Monitored Adherence Be Measured? A Comparison of 2 Evaluation Methods | HH De Keyser E Cooper JT Brinton SJ Szefler | 2024/5 | |
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma | The Journal of Allergy and Clinical Immunology: In Practice | Ronina Covar Stephen C Lazarus Jerry A Krishnan Kathryn V Blake Christine A Sorkness | 2024/4/1 |
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population | The Journal of Allergy and Clinical Immunology: In Practice | Jonathan Corren Stanley J Szefler Ellen Sher Phillip Korenblat Weily Soong | 2024/2/14 |
Fifty Years of Unraveling the Clinical Pharmacology of Corticosteroids | Kathryn E Kyler Stanley J Szefler | 2023/10/14 | |
Reviews and feature articles | Tuomas Jartti James E Gern Michael R Edwards Katherine Strong Aoife Cameron | 2017 | |
Digital health in difficult-to-treat severe asthma | The Lancet Respiratory Medicine | William W Busse Stanley J Szefler | 2023/7/1 |
Encouraging adherence in adolescents with asthma using financial incentives: An RCT | Pediatric Pulmonology | Heather H De Keyser John T Brinton Samantha Bothwell Megan Camacho Allison Kempe | 2023/10 |
Treating asthma in the time of COVID | Tara F Carr Merritt L Fajt Monica Kraft Wanda Phipatanakul Stanley J Szefler | 2023/4/1 | |
399 Pooled safety analysis of lebrikizumab in patients with uncontrolled asthma from three randomized clinical trials | British Journal of Dermatology | Jonathan Corren Stanley J Szefler April W Armstrong Chitra R Natalie Ralph Zitnik | 2023/6 |
How much change in FEV1 is associated with an increased risk of an asthma exacerbation? | Stephen Turner Nicole Filipow Francoise Vermeulen Robin Vael Thomas Frischer | 2023/9/9 | |
Factors to consider in prescribing asthma biologic therapies to children | The Journal of Allergy and Clinical Immunology: In Practice | William C Anderson III Tina M Banzon Bo Chawes Nikolaos G Papadopoulos Wanda Phipatanakul | 2023/3/1 |
Medication Adherence in Severe Asthma Patients Enrolling in the NHLBI Precise Study | P Akuthota T Song A Ivanova D Stempel SJ Szefler | 2023/5 | |
Deriving a change score for FEV1 for children with asthma | Nicole Filipow Stephen Turner Anne Chang Helen Petsky Thomas Frischer | 2023/9/9 | |
Is the assessment of asthma treatment efficacy sufficiently comprehensive? | David A Stempel Stanley J Szefler | 2023/12/20 | |
Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II) | Journal of Allergy and Clinical Immunology | Stanley Szefler Jonathan Corren Jonathan Silverberg Angela Okragly Zhe Sun | 2023/2/1 |
Dupilumab Induces Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma | ID Pavord E Israel SJ Szefler G Brusselle KF Rabe | 2023/5 | |
Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma | Allergy | Nikolaos G Papadopoulos Stanley J Szefler Leonard B Bacharier Jorge F Maspero Christian Domingo | 2023/8 |
Developing a Social Determinants of Health Needs Assessment for Colorado Kids (SNACK) Tool for a School-Based Asthma Program: Findings from a Pilot Study | Ethnicity and Disease | Sarah E Brewer Lisa R DeCamp Julia Reedy Rachel Armstrong Heather H DeKeyser | 2023/12/1 |
The Effect of Lebrikizumab on Inflammatory Biomarkers in Patients with Asthma. | touchREVIEWS in Respiratory & Pulmonary Diseases | Stanley J Szefler Jonathan Corren Jonathan Silverberg Angela Okragly Zhe Sun | 2023/1/1 |
Respiratory Impedance Corresponds to Clinical Outcomes in Children With Acute Asthma Exacerbations in the Pediatric Emergency Department | N Navanandan RD Mistry C Muller A Edid JB Brinton | 2023/5 |
